Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
SBI Mutual Fund

SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment

NAV
returns change indicator
97.4125
as on 25 Feb 2020, 10:55 PM
-0.5659(0.58%)
Last Change
loaderloader

Schemes Managed By

Start SIP in this Mutual Fund

Min SIP Amount
500
Suggested Date
26th of Every Month

Investment Performance

would have given a return of
110,871
star
121,647
star
95,293
star
98,572
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
1,428
Profit (absolute return)
1.43%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
9.25%
In the last 6 months
20.70%
In the last 1 year
14.11%
In the last 3 years
1.43%
In the last 5 years
14.51%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment
SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment
as of 25 Feb 2020, 10:55 PM
956.39 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 15 days
1.31%
Expense Ratio
Plan
Dividend
1.04%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 15 days
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Jan 2020
Sort By
Healthcare
98.35%
940.61 Cr
Cash Holding
1.04%
9.95 Cr
Construction
0.61%
5.83 Cr

Companies Holding in this Mutual Fund

as on 31 Jan 2020
Sort By
Divi's Laboratories Ltd.
9.19%
87.89 Cr
Lupin Ltd.
7.36%
70.39 Cr
Cipla Ltd.
7.01%
67.04 Cr
Sun Pharmaceutical Inds. Ltd.
6.81%
65.13 Cr
Strides Pharma Science Ltd.
5.39%
51.55 Cr
Abbott India Ltd.
5.23%
50.02 Cr
Torrent Pharmaceuticals Ltd.
5.05%
48.30 Cr
Alkem Laboratories Ltd.
5.01%
47.92 Cr
Alembic Pharmaceuticals Ltd.
4.95%
47.34 Cr
Ajanta Pharma Ltd.
4.64%
44.38 Cr
View All
View All

About SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment

SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Tanmaya Desai. It has an AUM of ₹956.39 Crores and the latest NAV decalared is ₹97.413 as on 25 Feb 2020 at 10:55 pm.
SBI Healthcare Opportunities Fund Direct Plan - Dividend Reinvestment scheme return performance in last 1 year is 14.11%, in last 3 years is -1.43% and 132.00% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.

Scheme Details

AUM:956.39 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

AMC Information

SBI Mutual Fund
SBI Mutual Fund
View AMC Details
382,691.71 Cr
AUM
104
Schemes
Address
Address
9th Floor-Crescenzo, C-38 & 39-G Block, Bandra-Kurla Complex,Bandra (East)400051
Phone Number
Phone Number
Phone : 022-61793000 / 1800-425-5425
Fax : 022-22189663